VetEntheogenic Rigorous research at the intersection of veterinary science and entheogens

VetEntheogenic

Rigorous research at the intersection of veterinary science and entheogens

Latest Articles

Three Decades in the Call Log: Reconstructing the Hidden History of DMT Plant Exposures in American Pets
Clinical Toxicology

Three Decades in the Call Log: Reconstructing the Hidden History of DMT Plant Exposures in American Pets

Long before grow kits hit mainstream commerce, regional poison centers and the ASPCA Animal Poison Control Center were quietly logging exposures to DMT-containing ornamentals and forage grasses. A retrospective reading of those records reveals patterns — geographic, seasonal, and species-specific — that today's veterinary toxicology infrastructure is still unprepared to act on.
The Adjuster's Dilemma: Who Pays When the Toxin Comes From a Grow Tent, Not the Trash Can?
Clinical Toxicology

The Adjuster's Dilemma: Who Pays When the Toxin Comes From a Grow Tent, Not the Trash Can?

When a dog presents with mydriasis and ataxia after a suspected psilocybin ingestion, the clinical questions are straightforward. The financial ones are not. This commentary examines how pet insurers classify entheogenic exposure claims — and why the answer matters for veterinary practice.
Uncontrolled Variables in the Barn Aisle: What Hemp Country's Horses Are Teaching Equine Toxicologists
Clinical Toxicology

Uncontrolled Variables in the Barn Aisle: What Hemp Country's Horses Are Teaching Equine Toxicologists

Across Kentucky, Colorado, and Oregon, working horses graze fence lines within reach of one of the least studied cannabinoid exposure experiments in American agriculture. Large-animal practitioners are quietly assembling the case data that no institutional review board ever approved.
A Century Before LSD: How Livestock Veterinarians Mapped Serotonin Receptor Toxicology in the Feed Bunk
Clinical Toxicology

A Century Before LSD: How Livestock Veterinarians Mapped Serotonin Receptor Toxicology in the Feed Bunk

Long before psychedelic science named the 5-HT2A receptor, generations of American livestock veterinarians were diagnosing and managing ergot alkaloid poisoning in cattle and sheep. This overlooked body of agricultural toxicology may hold practical lessons for researchers working with serotonergic compounds today.
A Calendar of Exposure: Mapping the Seasonal Rhythm of Entheogenic Plant Risks in American Backyards
Clinical Toxicology

A Calendar of Exposure: Mapping the Seasonal Rhythm of Entheogenic Plant Risks in American Backyards

Companion animal exposures to psychoactive plants do not occur randomly across the calendar — they cluster by climate zone, cultivation cycle, and harvest season. This analysis assembles a practical regional risk calendar for US practitioners and identifies the geographic gaps in current surveillance data.
The Missing Ledger: Why America's Adverse Event System Never Sees Animal Psychedelic Exposures
Clinical Toxicology

The Missing Ledger: Why America's Adverse Event System Never Sees Animal Psychedelic Exposures

When a dog ingests psilocybin mushrooms or a parrot is dosed with ayahuasca, the case rarely reaches any federal database. We examine the structural blind spots in US veterinary pharmacovigilance and what practitioners can do to close them.
Silence at the Exam Table: When Reporting a Client's Grow Room Could Cost the Next Animal Its Life
Research Ethics

Silence at the Exam Table: When Reporting a Client's Grow Room Could Cost the Next Animal Its Life

A limping terrier presents with mydriasis and tachycardia; on the wall calendar behind the owner, a hand-drawn diagram of a Salvia bed. What a veterinarian does next sits in one of American practice law's murkiest corners. This piece maps the state-by-state reporting landscape and argues that confidentiality is not just a courtesy — it is a public-health instrument.
Small Minds, Big Questions: Rethinking Invertebrate Welfare When Bees Visit the Passionflower
Research Ethics

Small Minds, Big Questions: Rethinking Invertebrate Welfare When Bees Visit the Passionflower

When honeybees forage on morning glory nectar or caterpillars consume serotonin-rich passionflower foliage, does anyone owe them moral consideration? As US ethics frameworks expand toward invertebrates, entheogenic botany sits at an uncomfortable intersection of neurobiology, philosophy, and policy.
Reading the Roadkill Ledger: What Wildlife Necropsy Data Quietly Says About Entheogenic Exposure
Clinical Toxicology

Reading the Roadkill Ledger: What Wildlife Necropsy Data Quietly Says About Entheogenic Exposure

State wildlife pathology labs and veterinary diagnostic networks are increasingly flagging psychoactive plant residues in free-ranging animals — often incidentally, and often without a screening protocol designed to catch them. This investigation examines what necropsy databases reveal about secondary exposure pathways, and why the current toxicology checklist may be missing an entire class of compounds.
Charted in the Dark: Inside the Counterfeit Dosing Guides Circulating Through Encrypted Pet-Drug Channels
Clinical Toxicology

Charted in the Dark: Inside the Counterfeit Dosing Guides Circulating Through Encrypted Pet-Drug Channels

Fabricated veterinary dosing charts for psychoactive compounds are spreading through encrypted marketplaces faster than regulators can catalog them. This analysis examines the labeling and telehealth gaps that sustain the trade, and why the clinical fallout lands in emergency animal hospitals with no paper trail.
Blind Spots on the Mass Spec: Inside the Analytical Void Facing Vets After Unknown Psychedelic Exposures
Clinical Toxicology

Blind Spots on the Mass Spec: Inside the Analytical Void Facing Vets After Unknown Psychedelic Exposures

When a dog presents with mydriasis, agitation, and hyperthermia of unknown origin, the answer may be a synthetic tryptamine no commercial panel is designed to detect. We speak with laboratory directors about the widening gap between what animals ingest and what American toxicology labs can actually see.
Living Collections, Lax Ledgers: Auditing How US Zoos and Botanical Gardens Account for Psychoactive Plants
Research Ethics

Living Collections, Lax Ledgers: Auditing How US Zoos and Botanical Gardens Account for Psychoactive Plants

The Memphis Zoo salvia incident raised an uncomfortable question: who is actually watching the psychoactive botanicals growing in America's public collections? An examination of DEA scheduling, AZA accreditation standards, and the policy vacuum surrounding living entheogenic specimens.
Desert Milk and Dark Web Vials: Tracing the Untold Supply Lines Behind America's 5-MeO-DMT Retreat Boom
Clinical Toxicology

Desert Milk and Dark Web Vials: Tracing the Untold Supply Lines Behind America's 5-MeO-DMT Retreat Boom

As 5-MeO-DMT tourism accelerates across the American Southwest, a parallel logistics network of toad milkers, synthetic analog vendors, and unlicensed facilitators has emerged largely outside regulatory view. Veterinary toxicologists and wildlife enforcement officials say the animals are the earliest warning system — and the data is slipping through their fingers.
The Mimic Problem: Five Diagnostic Traps Where Psychedelic Exposure Fooled the Differentials
Research Ethics

The Mimic Problem: Five Diagnostic Traps Where Psychedelic Exposure Fooled the Differentials

Anonymized case reports from small-animal practices reveal a recurring pattern: entheogen exposures presenting as garden-variety toxicities, confounding workups and delaying treatment. We walk through five instructive cases and extract the practical red flags every US practitioner should keep on the whiteboard.
Prescription from the Grow Kit: What Happens When Owners Self-Dose Their Dogs with Psilocybin
Research Ethics

Prescription from the Grow Kit: What Happens When Owners Self-Dose Their Dogs with Psilocybin

When a client admits to microdosing their anxious dog with psilocybin, veterinarians face a collision between confidentiality duties, mandatory reporting statutes, and the absence of any validated clinical protocol. This opinion piece argues that a formal harm-reduction framework is overdue — and that silence is itself an ethical position.
From Knockout Mice to Cephalopod Brains: Six Animal Models Upending Psychedelic Pharmacology
Clinical Toxicology

From Knockout Mice to Cephalopod Brains: Six Animal Models Upending Psychedelic Pharmacology

A survey of six landmark and emerging animal studies — from 5-HT2A knockout mice to octopus serotonin signaling — reveals how dramatically psychedelic pharmacology varies across species. Each finding carries practical weight for veterinary medicine and flags open questions that US academic labs are uniquely positioned to answer.
Amphibians at the Margins: What the 5-MeO-DMT Boom Means for the Sonoran Desert Toad
Research Ethics

Amphibians at the Margins: What the 5-MeO-DMT Boom Means for the Sonoran Desert Toad

As demand for 5-MeO-DMT surges, the Colorado River toad has become an unwitting commodity in the entheogenic economy. This analysis examines the welfare science, regulatory blind spots, and conservation pressures shaping the ethics of toad-based harvesting in the American Southwest.
Teaching the Molecule: Five US Veterinary Programs Building Psychedelic Literacy into the Curriculum
Clinical Toxicology

Teaching the Molecule: Five US Veterinary Programs Building Psychedelic Literacy into the Curriculum

Most US veterinary graduates will encounter psychedelic compounds in practice — in a dog that ate a stash of edibles, a parrot exposed to secondhand vapor, a horse dosed from a questionable supply chain. A handful of programs are beginning to teach for that reality. We profile five.
Serotonin, Species, and Wishful Thinking: What Veterinary Medicine Should — and Shouldn't — Take from Psychedelic Drug Development
Clinical Toxicology

Serotonin, Species, and Wishful Thinking: What Veterinary Medicine Should — and Shouldn't — Take from Psychedelic Drug Development

Cross-pollination between human psychedelic pharmacology and veterinary therapeutics is accelerating, from receptor-binding assays to drug interaction screening. But not every translational shortcut is safe — and some anthropomorphic extrapolations could harm the very patients they aim to help.
Before the First Dose: How IACUCs Are Grappling with Schedule I Compounds in the Animal Lab
Research Ethics

Before the First Dose: How IACUCs Are Grappling with Schedule I Compounds in the Animal Lab

Institutional animal care committees have become the de facto arbiters of psychedelic science's foundations, yet few were designed to evaluate these compounds. We examine the regulatory friction points, the welfare questions unique to serotonergic agents, and what 2025's rescheduling chatter means for oversight at the bench.